WASHINGTON DC, (Reuters): US President Joe Biden continues to feel “very well” while still testing positive for COVID-19, the White House physician said on Friday. Biden...
WASHINGTON DC, (Reuters): Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or...
WASHINGTON, (Reuters): Pfizer Inc and BioNTech have asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged five to 11, Pfizer said...
WASHINGTON DC, (Reuters): Pfizer Inc and BioNTech SE on Tuesday submitted initial trial data for their COVID-19 vaccine in 5-11 year olds and said they would...
Washington: Moderna’s COVID-19 vaccine brought in more than USD 4 billion in second-quarter sales, helping to push the vaccine developer into a profit. The company also...